Market Overview

Feltl and Company Lowers PT on DexCom to $9

Feltl and Company has lowered the price target on DexCom (NASDAQ: DXCM) from $10 to $9 and maintains its Hold rating.

Posted-In: Feltl And CompanyPrice Target Pre-Market Outlook Analyst Ratings


Related Articles (DXCM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional